Use of KENT Homoeopathic Repertory in treatment of Irritable Bowel Syndrome

A Clinical Study On The Utility Of Kent Repertory In The Treatment Of Irritable Bowel Syndrome - NIL

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/06/089711

Enrollment

Registered

2025-06-27

Start date

Unknown

Completion date

Unknown

Last updated

2025-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K582- Mixed irritable bowel syndrome

Interventions

Intervention1: Constitutional Homoeopathic Medicine: Kent Homoeopathic Repertory is consulted for repertorozation and medicine will be prescribed.Potency will be used from 6C, 30C,200C,1M,10M. Medicin

Eligibility

Inclusion criteria

Inclusion criteria: .Patients following ROME IV criteria will be included .Patients of both sexes will be included .Patients of 25-40 years of age will included .Patients of all religion and different socio- economic status will be included .Patients who give consent for Homoeopathic treatment will be included .Patients having no co-morbidity will be included

Exclusion criteria

Exclusion criteria: .Patient suffering from any systemic illness will be excluded .Age below 25 years and above 40 Years will be excluded .Patient who do not give consent for Homoeopathic treatment will be excluded .Patient having any pathological abnormality will be excluded .Pregnancy condition will be excluded.

Design outcomes

Primary

Measure	Time frame
It is expected from the study that it will increase the scope of KENT Homoeopathic repertory in selecting homoeopathic medicines in the treatment of Gastro intestinal disordes especilally in Irritable Bowel Syndrome and will provide a good alternative to the conventional mode of treatment with no side effects. It will also bring statistically more significant changes in the ROME Criteria.Timepoint: 3-4 MONTHS	—

Measure

Time frame

It is expected from the study that it will increase the scope of KENT Homoeopathic repertory in selecting homoeopathic medicines in the treatment of Gastro intestinal disordes especilally in Irritable Bowel Syndrome and will provide a good alternative to the conventional mode of treatment with no side effects. It will also bring statistically more significant changes in the ROME Criteria.Timepoint: 3-4 MONTHS

—

Secondary

Measure	Time frame
To find out group of homoeopathic medicines effective in managing the cases of Irritable Bowel Syndrome and To see the changes in Patient-Oriented ROME CriteriaTimepoint: 3-4 months	—

Countries

India

Contacts

Public ContactDr Ram Kumar

RBTS Government Homoeopathic Medical College and Hospital

drramkumar26@gmail.com9006930950

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026